Long-Term Use and Cost-Effectiveness of Secondary Prevention Medications for Heart Disease in Western Australian Seniors

点击翻译按钮获取中文摘要

Clinical trials show that long-term treatment with selected medicines greatly reduces the risk of further heart attacks or stroke in persons with known heart disease. Levels of such prescribing is high when patients are discharged from hospital, but the extent to which patients continue with long-term treatment is unknown. We will investigate compliance with treatment, and the costs and effectiveness of these medicines in a population study of patients aged 65 years or more in Western Australia.